期刊文献+

间充质干细胞体外修饰治疗急性肾损伤的研究进展 被引量:1

原文传递
导出
摘要 急性肾损伤(AKI)是以肾功能迅速下降为特征的一组综合征,病情进展至后期则演变为急性肾衰竭,多由于手术、外伤、放射介入以及肿瘤化疗等所诱发。据不完全统计,AKI在中国综合性医院总发病率为5%~18%,在重症监护病房则高达67%,病死率30%-80%。
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2013年第3期232-236,共5页 Chinese Journal of Nephrology
基金 基金项目:国家自然科学基金(81000307) 上海市科委基础研究重大项目(12DJ1400200)
  • 相关文献

参考文献40

  • 1Fang Y, Ding X, Zhong Y, et al. Acute kidney injury in aChinese hospitalized population. Blood Purif, 2010, 30: 120 -126.
  • 2Vemuri MC, Chase LG, Hao MS. Mesenchymal stem cell assaysand applications. Methods Mol Biol, 2011, 698: 3-8.
  • 3Casteilla L,Planat - Benard V, Bourin P, et al. Use of adiposetissue in regenerative medicine. Transfus Clin Biol, 2011, 18:124-128.
  • 4Ding DC, Shyu WC, Lin SZ. Mesenchymal stem cells. CellTransplant, 2011,20: 5-14.
  • 5Dominici M,Le Blanc K, Mueller I,et al. Minimal criteria fordefining multipotent mesenchymal stromal cells. TheInternational Society for Cellular Therapy position statement.Cytotherapy, 2006,8: 315-317.
  • 6Griffin MD, Ritter T, Mahon BP. Immunological aspects ofallogeneic mesenchymal stem cell therapies. Hum Gene Ther,2010,21: 1641-1655.
  • 7McTaggart SJ, Atkinson K. Mesenchymal stem cells:immunobiology and therapeutic potential in kidney disease.Nephrology, 2007, 12: 44-52.
  • 8Sadan 0, Melamed E, Offen D. Bone - marrow - derivedmesenchymal stem cell therapy for neurodegenerative diseases.Expert Opin Biol Ther, 2009, 9: 1487-1497.
  • 9Aurich H, Sgodda M, Kaltwasser P, et al. Hepatocytedifferentiation of mesenchymal stem cells from human adiposetissue in vitro promotes hepatic integration in vivo. Gut, 2009,58: 570-581.
  • 10Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymalstem cells differentiate to a cardiomyocyte phenotype in theadult murine heart. Circulation, 2002,105: 93-98.

二级参考文献11

  • 1Tang J, Xie Q, Pan G, et al. Mesenchymal stem cells participate angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusian. Eur J Cardiothorac Surg, 2006,3 : 353- 361.
  • 2Kunter U, Rong S, Boor P, et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrel,2007, 18 : 1754-1764.
  • 3Sagrinati C, Ronconi E, Lazzeri E, et al. Stem-cell approaches for kidney repair: choosing the right cells. Trends Mol Med ,2008, 14:277-285.
  • 4Torras J, Herrero-Fresneda I, Lloberas N, et al. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int, 2002,61:2218-2227.
  • 5I Hu X, Yu SP, Fraser JL, et al. Transplantation of hypoxia- preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorae Cardiovasc Surg, 2008, 135: 799-808.
  • 6Volkmer E, Kallukalam BC, Maertz J, et al. Hypoxic preconditioning of human mesenchymal stem cells overcomes hypoxia-induced inhibition of osteogenic differentiation. Tissue Eng Part A, 2010, 16: 153-164.
  • 7Wright DE, Bowman EP, Wagers A J, et al. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med, 2002, 195: 1145-1154.
  • 8Honczarenko M, Le Y, Swierkowski M, et al. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells,2006, 24 : 1030-1041.
  • 9Jiang SH, Liu CF, Zhang XL, et al. Renal protection by delayed ischaemic preconditioning is associated with inhibition of the inflammatory response and NF-kappaB activation. Cell Biochem Funct. 2007,25 : 335-343.
  • 10Bernhardt WM, C~tmpean V, Kany S, et al. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure. J Am Soc Nephrol, 2006, 17 : 1970-1978.

共引文献13

同被引文献14

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部